Positive modulators of nicotinic receptor agonists
    6.
    发明授权
    Positive modulators of nicotinic receptor agonists 失效
    烟碱受体激动剂的阳性调节剂

    公开(公告)号:US06750242B1

    公开(公告)日:2004-06-15

    申请号:US10111027

    申请日:2002-09-23

    IPC分类号: A61K31404

    摘要: Compounds of Formula I wherein R1, R2, R3 and R4 are as defined in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. The compounds of the invention enhance the efficacy of agonists at nicotinic receptors.

    摘要翻译: R 1,R 2,R 3和R 4中的式I化合物如本说明书中所定义,其对映体,其药学上可接受的盐,制备方法,含有它们的药物组合物及其用途 在治疗中,特别是用于治疗与烟碱传播减少有关的病症。 本发明的化合物增强了激动剂在烟碱受体上的功效。

    Positive modulators of nicotinic receptor agonists
    7.
    发明授权
    Positive modulators of nicotinic receptor agonists 失效
    烟碱受体激动剂的阳性调节剂

    公开(公告)号:US07402604B2

    公开(公告)日:2008-07-22

    申请号:US11178668

    申请日:2005-07-11

    IPC分类号: A61K31/405 C07D209/42

    摘要: Compounds according to formula I: wherein R1, W, R2, R3, X, R4 and R5 are as described in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission.

    摘要翻译: 根据式I的化合物:其中R 1,W,R 2,R 3,X,R 4, 和R 5如说明书中所述,其对映体,其药学上可接受的盐,其制备方法,含有它们的药物组合物及其在治疗中的用途,特别是用于治疗与烟碱减少有关的病症 传输。

    Positive modulators of nicotinic receptor agonists
    8.
    发明授权
    Positive modulators of nicotinic receptor agonists 失效
    烟碱受体激动剂的阳性调节剂

    公开(公告)号:US07064143B1

    公开(公告)日:2006-06-20

    申请号:US10111029

    申请日:2000-11-01

    IPC分类号: A61K31/404 C07D209/04

    摘要: Compounds of Formula I wherein R1, R2, R3, R4, R5, W and X as defined in the specification, enantiomers thereof, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. Compounds of the invention enhance the efficacy of agonists at nicotinic receptors.

    摘要翻译: 式I的化合物,其中R 1,R 2,R 3,R 4,R 5, 本说明书中定义的对映异构体,其药学上可接受的盐,其制备方法,含有它们的药物组合物及其在治疗中的用途,特别是用于治疗与烟碱转​​移相关的病症相关的病症。 本发明的化合物增强了激动剂在烟碱受体上的功效。

    Positive modulators of nicotinic receptor agonists
    9.
    发明授权
    Positive modulators of nicotinic receptor agonists 失效
    烟碱受体激动剂的阳性调节剂

    公开(公告)号:US06756398B1

    公开(公告)日:2004-06-29

    申请号:US10111028

    申请日:2002-04-18

    IPC分类号: C07D20908

    摘要: Compounds of Formula I wherein R1a, R1b, R2b, R3b, R3a, R2a, B1, B2, Z, A2 and A1 are as defined in the specification, enantiomers thereof, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. Compounds of the invention enhance the efficacy of agonists at nicotinic receptors.

    摘要翻译: R 1,R 1b,R 2b,R 3b,R 3a,R 2a,B 1,B 2,Z,A 2中的式I化合物, 和A 1如本说明书中所定义,其对映异构体,其药学上可接受的盐,制备方法,含有它们的药物组合物及其在治疗中的用途,特别是用于治疗与烟碱传递减少有关的病症。 本发明的化合物增强了激动剂在烟碱受体上的功效。